[Federal Register Volume 59, Number 199 (Monday, October 17, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-25636]


[[Page Unknown]]

[Federal Register: October 17, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 94N-0287] 
 

Glaxo, Inc., et al.; Withdrawal of Approval of 13 Abbreviated 
Antibiotic Applications and 2 Abbreviated New Drug Applications; 
Correction 
AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of August 4, 1994 (59 FR 39773). 
The document withdrew approval of 13 abbreviated antibiotic 
applications (AADA's) and 2 abbreviated new drug applications (ANDA's). 
The document was published with a typographical error. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy 
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-443-2994.

SUPPLEMENTARY INFORMATION: In FR Doc. 94-18971 appearing on page 39773 
in the Federal Register of Thursday, August 4, 1994, the following 
correction is made:
    On page 39773, in the first column of the table, the application 
no. ``AADA 629-053'' is corrected to read ``AADA 62-053''.

    Dated: October 5, 1994.
Janet Woodcock,
Director, Center for Drug Evaluation and Research.
[FR Doc. 94-25636 Filed 10-14-94; 8:45 am]
BILLING CODE 4160-01-F